A5022024455- Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Viral-associated cancers and disorders
- Hemoglobinopathies and Related Disorders
- Venous Thromboembolism Diagnosis and Management
- CAR-T cell therapy research
- Cutaneous lymphoproliferative disorders research
- Atrial Fibrillation Management and Outcomes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- T-cell and Retrovirus Studies
- Eosinophilic Disorders and Syndromes
- Diagnosis and Treatment of Venous Diseases
- Mosquito-borne diseases and control
- COVID-19 Clinical Research Studies
- Chronic Myeloid Leukemia Treatments
- Blood groups and transfusion
- Blood donation and transfusion practices
- Retinoids in leukemia and cellular processes
- Cardiac tumors and thrombi
- Vascular Tumors and Angiosarcomas
- COVID-19 and healthcare impacts
- Blood disorders and treatments
- Neutropenia and Cancer Infections
Rajavithi Hospital
2015-2024
Rangsit University
2023-2024
Technical University of Munich
2019
Abstract Systemic reports on the descriptive epidemiology of non‐Hodgkin lymphoma (NHL) from Southeast Asia are scarce. A nationwide multi‐institutional registry was conducted to compare histopathology, clinical features, and survival Thai adult patients with NHL using large registries, especially those Far East (FEA). Using a web‐based system, 13 major medical centers 4 geographic regions Thailand prospectively collected, 2007 2014, diagnostic pathology, according World Health Organization...
Background: Internationally established guidelines mention pharmacological prophylaxis for all hospitalized COVID-19 patients. However, there are concerns regarding the efficacy and safety of anticoagulants. This study investigated associations between thrombosis/bleeding risk scores clinical outcomes. Methods: We conducted a retrospective review adult patients admitted to two hospitals 2021 2022. analyzed data, laboratory results, low molecular weight heparin (LMWH) use, thrombosis,...
Objective This study aimed to evaluate the relationship between high-sensitivity C-reactive protein (hsCRP) in hospitalized COVID-19 patients and their clinical outcomes, including trajectory of hsCRP changes during hospitalization. Method results Patients with positive tests 2021 2023 were admitted two hospitals. Among 184 adult patients, approximately half (47.3%) had elevated levels upon admission, which defined as exceeding laboratory-specific upper limit test (> 5.0 mg/L)....
Event free survival at 24 months (EFS24) has been described as a powerful predictor for outcome in several subtypes of B cell lymphoma. However, it was limitedly T We explored the implication EFS24 marker peripheral lymphoma (PTCL). reviewed 293 systemic PTCL patients 13 nationwide major university hospitals Thailand from 2007 to 2014. The median event (EFS) and overall (OS) our cohort 16.3 27.7 with corresponding 2-year EFS OS 45.8% 51.9%, respectively. A total 118 achieved (no events...
The impact of health insurance with inequitable rituximab coverage on the survival patients diffuse large B-cell lymphoma (DLBCL) has never been reported. We conducted a nationwide multicenter analysis outcome 553 adult consecutively diagnosed DLBCL between July 2003 and June 2006, in whom treatment cost was reimbursed under Civil Servant Medical Benefit Scheme (CSMBS) (n =201) or Universal Coverage (UCS) =352). international prognostic index comparable two payment groups. Rituximab-based...
Background Thalassemia is a genetic hemoglobinopathy in which defective globin chain can cause transfusion-dependent anemia and other complications. As genotype interactions lead to variations the clinical course among patients with thalassemia, factors may help predict survival types of thalassemia complicated by gene interactions. Aim This study aimed determine associated thalassemia. We retrospectively reviewed medical records older than 15 years between 2002 2020 that were available at...
The survival rate of adult patients with Hodgkin lymphoma (HL) depends on the responses to standard chemotherapy, radiotherapy, or combined therapy. Resource-limited countries face numerous obstacles in supporting HL who undergo especially advanced stages.To analyze outcomes after combined-modality treatment (CMT) involved-field non-involved-field radiotherapy.We retrospectively reviewed medical records 90 received CMT at Rajavithi Hospital, Bangkok between 2007 and 2021. Patients stage I-IV...
Background: Polycythemia vera has been found in a wide range of hematopoietic tissue disorders, but rarely concomitant with renal abnormality. To our knowledge there is only one available report patient polycythemia angiomyolipoma, and the does not cover clinical course this rare finding. Objectives: presentation right angiomyolipoma. Methods: We retrospectively reviewed medical records who presented Results: Our mass diagnosed by point mutation gene for Janus kinase 2. The was as...
Background: Peripheral T cell lymphoma (PTCL) is relatively uncommon compared to B lymphoma, however, it generally carries worse prognosis. Treatment failure and early relapse are major dilemma of PTCL. Identification high-risk patients using various tools may better refine long-term prognosis PTCL patients. There were data indicating event free survival (EFS) at 12 months (EFS12) 24 (EFS24) as strong surrogate predictors for disease-related outcomes in many B-cell lymphoma. However, the...
Event-free survival at 12 months (EFS12) is a surrogate endpoint for long-term outcomes in many histologic lymphoma subtypes. However, most reports have primarily investigated the implication of EFS12 advanced-stage non-Hodgkin (NHL). There are limited data regarding significance early-stage NHL. Herein, we evaluated prognostic patients with stage 1 diffuse large B-cell (DLBCL). Out 282 DLBCL who received intensive therapy, 227 (80.5%) achieved EFS12. The 4-year overall (OS) was 91.4% and...
Abstract Severe dengue infection is associated with life-threatening complications, including severe bleeding. The bleeding tendency typically the shock phase of infection, for which blood replacement may be needed. However, repetitive transfusion can lead to volume overload. Administration recombinant activated factor VII (rFVIIa) might used counteract without inducing We describe case a patient who presented intractable bleeding; he was initially treated massive transfusions, resulted in...
Background: Primary granulocytic sarcoma (GS) only rarely presents with an ovarian mass classified as extramedullary myeloid progenitor tumor cells. Few patients cases of primary GS survive after systemic chemotherapy. Objective: To present a case treated complete course The patient is currently in remission. Methods: Retrospective review medical records and comparison previous reports. Results: A 41-year-old woman presented 6 months duration. There was no history hematologic disease or...